Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.7660
+0.0080 (1.06%)
May 4, 2026, 4:58 PM CET
Prostatype Genomics AB Revenue
In the year 2025, Prostatype Genomics AB had annual revenue of 594.00K SEK, down -69.03%. Prostatype Genomics AB had revenue of 348.00K in the half year ending December 31, 2025, a decrease of -86.95%.
Revenue
594.00K
Revenue Growth
-69.03%
P/S Ratio
76.33
Revenue / Employee
99.00K
Employees
6
Market Cap
45.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 594.00K | -1.32M | -69.03% |
| Dec 31, 2024 | 1.92M | -1.81M | -48.55% |
| Dec 31, 2023 | 3.73M | 3.05M | 445.83% |
| Dec 31, 2022 | 683.00K | -1.83M | -72.78% |
| Dec 31, 2021 | 2.51M | -498.13K | -16.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.52B |
| Camurus AB | 2.27B |
| ScandiDos AB | 56.85M |
| Newbury Pharmaceuticals AB | 32.78M |
| Nanologica AB | 21.13M |
| 2cureX AB | 1.98M |
Prostatype Genomics AB News
- 6 months ago - Prostatype Genomics AB Transcript: Life Science Summit 2025 - Transcripts